AC Immune SAのCurrent ratio
AC Immune SAのCurrent ratioは何ですか。
AC Immune SAのCurrent ratioは10.85です。
Current ratioの定義は何ですか。
流動比率は、同社が短期債務を履行するために十分なリソースを持っているかどうかを測定流動性比率です。
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
NASDAQのセクタHealth CareにおけるCurrent ratioの企業と比べるAC Immune SA
AC Immune SAは何をしますか。
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
AC Immune SAと類似のcurrent ratio
- Shanghai Qingpu Fire-Fighting Equipment CoのCurrent ratioは10.81です。
- Mainz Biomed B.V. Eo 1のCurrent ratioは10.83です。
- Security NationalのCurrent ratioは10.84です。
- uniQure N.VのCurrent ratioは10.84です。
- Surana SolarのCurrent ratioは10.84です。
- Time Watch InvestmentsのCurrent ratioは10.85です。
- AC Immune SAのCurrent ratioは10.85です。
- HB StockholdingsのCurrent ratioは10.86です。
- Uranium CorpのCurrent ratioは10.86です。
- Rafaella ResourcesのCurrent ratioは10.87です。
- OptimizeRxのCurrent ratioは10.88です。
- GKWのCurrent ratioは10.90です。
- Ballard Power SystemsのCurrent ratioは10.90です。